Platelet dysfunction in renal failure

Research output: Contribution to journalArticle

239 Citations (Scopus)

Abstract

Patients with end-stage renal disease suffer from complex hemostatic disorders. Uremic patients show a bleeding diathesis that is mainly due to abnormalities of primary hemostasis; in particular, platelet dysfunction and impaired platelet-vessel wall interaction. However, despite decreased platelet function, these patients have a high prevalence of cardiovascular and thrombotic complications. Platelet dysfunction in uremic patients is partially due to uremic toxins present in circulating blood. Dialysis improves platelet abnormalities and reduces, but does not eliminate, the risk of hemorrhage. Hemodialysis can even contribute to the bleeding through the continuous platelet activation induced by the interaction between blood and artificial surfaces. Thrombocytopenia, glomerular thrombosis, and thrombi in small arteries and glomerular capillaries are common pathological features in many renal diseases. Platelets are also involved directly in the pathogenesis of glomerular diseases through a variety of mechanisms, including release of active molecules, by enhancing immune complex deposition, and by altering glomerular permeability.

Original languageEnglish
Pages (from-to)579-589
Number of pages11
JournalSeminars in Thrombosis and Hemostasis
Volume30
Issue number5
DOIs
Publication statusPublished - Oct 2004

Fingerprint

Renal Insufficiency
Blood Platelets
Hemorrhage
Thrombosis
Hemostatic Disorders
Blood Substitutes
Disease Susceptibility
Platelet Activation
Antigen-Antibody Complex
Hemostasis
Thrombocytopenia
Chronic Kidney Failure
Renal Dialysis
Dialysis
Permeability
Arteries
Kidney

Keywords

  • Bleeding
  • Platelet
  • Renal diseases
  • Thrombosis
  • Uremia

ASJC Scopus subject areas

  • Hematology

Cite this

Platelet dysfunction in renal failure. / Boccardo, Paola; Remuzzi, Giuseppe; Galbusera, Miriam.

In: Seminars in Thrombosis and Hemostasis, Vol. 30, No. 5, 10.2004, p. 579-589.

Research output: Contribution to journalArticle

@article{ca7006c34eb54f6481a24b200f6c066c,
title = "Platelet dysfunction in renal failure",
abstract = "Patients with end-stage renal disease suffer from complex hemostatic disorders. Uremic patients show a bleeding diathesis that is mainly due to abnormalities of primary hemostasis; in particular, platelet dysfunction and impaired platelet-vessel wall interaction. However, despite decreased platelet function, these patients have a high prevalence of cardiovascular and thrombotic complications. Platelet dysfunction in uremic patients is partially due to uremic toxins present in circulating blood. Dialysis improves platelet abnormalities and reduces, but does not eliminate, the risk of hemorrhage. Hemodialysis can even contribute to the bleeding through the continuous platelet activation induced by the interaction between blood and artificial surfaces. Thrombocytopenia, glomerular thrombosis, and thrombi in small arteries and glomerular capillaries are common pathological features in many renal diseases. Platelets are also involved directly in the pathogenesis of glomerular diseases through a variety of mechanisms, including release of active molecules, by enhancing immune complex deposition, and by altering glomerular permeability.",
keywords = "Bleeding, Platelet, Renal diseases, Thrombosis, Uremia",
author = "Paola Boccardo and Giuseppe Remuzzi and Miriam Galbusera",
year = "2004",
month = "10",
doi = "10.1055/s-2004-835678",
language = "English",
volume = "30",
pages = "579--589",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "5",

}

TY - JOUR

T1 - Platelet dysfunction in renal failure

AU - Boccardo, Paola

AU - Remuzzi, Giuseppe

AU - Galbusera, Miriam

PY - 2004/10

Y1 - 2004/10

N2 - Patients with end-stage renal disease suffer from complex hemostatic disorders. Uremic patients show a bleeding diathesis that is mainly due to abnormalities of primary hemostasis; in particular, platelet dysfunction and impaired platelet-vessel wall interaction. However, despite decreased platelet function, these patients have a high prevalence of cardiovascular and thrombotic complications. Platelet dysfunction in uremic patients is partially due to uremic toxins present in circulating blood. Dialysis improves platelet abnormalities and reduces, but does not eliminate, the risk of hemorrhage. Hemodialysis can even contribute to the bleeding through the continuous platelet activation induced by the interaction between blood and artificial surfaces. Thrombocytopenia, glomerular thrombosis, and thrombi in small arteries and glomerular capillaries are common pathological features in many renal diseases. Platelets are also involved directly in the pathogenesis of glomerular diseases through a variety of mechanisms, including release of active molecules, by enhancing immune complex deposition, and by altering glomerular permeability.

AB - Patients with end-stage renal disease suffer from complex hemostatic disorders. Uremic patients show a bleeding diathesis that is mainly due to abnormalities of primary hemostasis; in particular, platelet dysfunction and impaired platelet-vessel wall interaction. However, despite decreased platelet function, these patients have a high prevalence of cardiovascular and thrombotic complications. Platelet dysfunction in uremic patients is partially due to uremic toxins present in circulating blood. Dialysis improves platelet abnormalities and reduces, but does not eliminate, the risk of hemorrhage. Hemodialysis can even contribute to the bleeding through the continuous platelet activation induced by the interaction between blood and artificial surfaces. Thrombocytopenia, glomerular thrombosis, and thrombi in small arteries and glomerular capillaries are common pathological features in many renal diseases. Platelets are also involved directly in the pathogenesis of glomerular diseases through a variety of mechanisms, including release of active molecules, by enhancing immune complex deposition, and by altering glomerular permeability.

KW - Bleeding

KW - Platelet

KW - Renal diseases

KW - Thrombosis

KW - Uremia

UR - http://www.scopus.com/inward/record.url?scp=7044239110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7044239110&partnerID=8YFLogxK

U2 - 10.1055/s-2004-835678

DO - 10.1055/s-2004-835678

M3 - Article

C2 - 15497100

AN - SCOPUS:7044239110

VL - 30

SP - 579

EP - 589

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 5

ER -